Patent protection, creative destruction, and generic entry in pharmaceuticals: evidence from patent and pricing data
This paper merges patent citation data with data on pharmaceutical patent expirations, generic entry, and pricing to explore the effects of observable patent characteristics on off-patent and on-patnet pharmaceutical pricing. Using a sample of drug patents facing generic entry in...